Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Paranodal permeability in "myelin mutants".

Seema Shroff | Amanda Mierzwa | Steven S Scherer | Elior Peles | Juan C Arevalo | Moses V Chao | Jack Rosenbluth
Glia | 2011

Fluorescent dextran tracers of varying sizes have been used to assess paranodal permeability in myelinated sciatic nerve fibers from control and three "myelin mutant" mice, Caspr-null, cst-null, and shaking. We demonstrate that in all of these the paranode is permeable to small tracers (3 kDa and 10 kDa), which penetrate most fibers, and to larger tracers (40 kDa and 70 kDa), which penetrate far fewer fibers and move shorter distances over longer periods of time. Despite gross diminution in transverse bands (TBs) in the Caspr-null and cst-null mice, the permeability of their paranodal junctions is equivalent to that in controls. Thus, deficiency of TBs in these mutants does not increase the permeability of their paranodal junctions to the dextrans we used, moving from the perinodal space through the paranode to the internodal periaxonal space. In addition, we show that the shaking mice, which have thinner myelin and shorter paranodes, show increased permeability to the same tracers despite the presence of TBs. We conclude that the extent of penetration of these tracers does not depend on the presence or absence of TBs but does depend on the length of the paranode and, in turn, on the length of "pathway 3," the helical extracellular pathway that passes through the paranode parallel to the lateral edge of the myelin sheath.

Pubmed ID: 21618613

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS043174-09
  • Agency: NINDS NIH HHS, United States
    Id: NS50220
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS021072
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050220-07
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS037475
  • Agency: NICHD NIH HHS, United States
    Id: HD23315
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS050220
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS037475-09
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS021072-25
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS043174
  • Agency: NICHD NIH HHS, United States
    Id: P01 HD023315
  • Agency: NINDS NIH HHS, United States
    Id: NS 37475
  • Agency: NINDS NIH HHS, United States
    Id: NS21072
  • Agency: NINDS NIH HHS, United States
    Id: NS43174
  • Agency: NINDS NIH HHS, United States
    Id: R56 NS021072

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Jackson ImmunoResearch (tool)

RRID:SCR_010488

A commercial antibody vendor, specializing in secondary antibodies.

View all literature mentions